Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: Findings from the breast cancer family registry

Journal of Clinical Oncology

Volumn 29, Issue 34, 2011, Pages 4505-4509

  Kurian, Allison W ^a   Gong, Gail D ^a   John, Esther M ^a,b   Johnston, David A ^a   Felberg, Anna ^a   West, Dee W ^a,b   Miron, Alexander ^c   Andrulis, Irene L ^d,e,f   Hopper, John L ^g   Knight, Julia A ^d,e   Ozcelik, Hilmi ^d,e   Dite, Gillian S ^g   Apicella, Carmel ^g   Southey, Melissa C ^g   Whittemore, Alice S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MOUNT SINAI HOSPITAL   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f CANCER CARE ONTARIO   (Canada)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CELL HETEROGENEITY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEREDITY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; INCIDENCE; MIDDLE AGED; MUTATION; REGISTRIES; RISK FACTORS;

EID: 83355174088     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.34.4440     Document Type: Article

References (29)

1. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130, 2003 (Pubitemid 36530000)
2. Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25: 1329-1333, 2007 (Pubitemid 46706879)
3. Daly MB, Axilbund JE, Buys S, et al: Genetic/ familial high-risk assessment: Breast and ovarian. J Natl Compr Canc Netw 8:562-594, 2010
4. Smith A, Moran A, Boyd MC, et al: Phenocopies in BRCA1 and BRCA2 families: Evidence for modifier genes and implications for screening. J Med Genet 44:10-15, 2007 (Pubitemid 46142833)
5. Gronwald J, Cybulski C, Lubinski J, et al: Phenocopies in breast cancer 1 (BRCA1) families: Implications for genetic counselling. J Med Genet 44:e76, 2007
6. Rowan E, Poll A, Narod SA: A prospective study of breast cancer risk in relatives of BRCA1/ BRCA2 mutation carriers. J Med Genet 44:e89, 2007
7. Domchek SM, Gaudet MM, Stopfer JE, et al: Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res Treat 119:409-414, 2010
8. Korde LA, Mueller CM, Loud JT, et al: No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families. Breast Cancer Res Treat 125:169- 173, 2011
9. Eisinger F: Phenocopies: Actual risk or self-fulfilling prophecy? J Med Genet 44:e87, 2007
10. John EM, Hopper JL, Beck JC, et al: The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6:R375-R389, 2004
11. Neuhausen SL, Ozcelik H, Southey MC, et al: BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: An open resource for collaborative research. Breast Cancer Res Treat 116: 379-386, 2009
12. Whittemore AS, Halpern J: Multi-stage sampling in genetic epidemiology. Stat Med 16:153-167, 1997 (Pubitemid 27029294)
13. Ganguly A, Rock MJ, Prockop DJ: Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci U S A 90: 10325-10329, 1993 (Pubitemid 23328305)
14. Körkkö J, Annunen S, Pihlajamaa T, et al: Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: Comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci U S A 95:1681-1685, 1998 (Pubitemid 28103453)
15. Davies H, Dicks E, Stephens P, et al: High throughput DNA sequence variant detection by conformation sensitive capillary electrophoresis and automated peak comparison. Genomics 87:427-432, 2006 (Pubitemid 43214515)
16. Velasco E, Infante M, Durán M, et al: Heteroduplex analysis by capillary array electrophoresis for rapid mutation detection in large multiexon genes. Nat Protoc 2:237-246, 2007 (Pubitemid 47040089)
17. John EM, Miron A, Gong G, et al: Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869-2876, 2007
18. Andrulis IL, Anton-Culver H, Beck J, et al: Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat 20:65-73, 2002 (Pubitemid 34747718)
19. Dite GS, Whittemore AS, Knight JA, et al: Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. Br J Cancer 103:1103-1108, 2010
20. National Human Genome Research Institute: Breast Cancer Information Core. http://research.nhgri .nih.gov/bic/
21. Antoniou AC, Easton DF: Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 25:190-202, 2003 (Pubitemid 37296594)
22. Gong G, Hannon N, Whittemore AS: Estimating gene penetrance from family data. Genet Epidemiol 34:373-381, 2010
23. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130, 2004 (Pubitemid 38477070)
24. Kalbfleisch JD, Lawless JF: Likelihood analysis of multi-state models for disease incidence and mortality. Stat Med 7:149-160, 1988 (Pubitemid 18045527)
25. Anderson H, Bladstrom A, Olsson H, et al: Familial breast and ovarian cancer: A Swedish population-based register study. Am J Epidemiol 152:1154-1163, 2000 (Pubitemid 32005753)
26. Pharoah PD, Antoniou A, Bobrow M, et al: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36, 2002
27. Goldgar D, Venne V, Conner T, et al: BRCA phenocopies or ascertainment bias? J Med Genet 44:e86, 2007
28. Begg CB: On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221-1226, 2002
29. Amir E, Freedman OC, Seruga B, et al: Assessing women at high risk of breast cancer: A review of risk assessment models. J Natl Cancer Inst 102:680-691, 2010